Do you want to read an article? Please log in or register.
BALANCING CARDIOVASCULAR BENEFIT AND DIABETOGENIC HARM OF THERAPY WITH STATINS: REAL-WORLD EVIDENCE FROM ITALY
Type 2 Diabetes
Related content
Diabetes - General
Interpretation of the evidence for the efficacy and safety of statin therapy
Lancet.
Collins R, Reith C, Emberson J, Armitage J, Baigent C, Blackwell L, Blumenthal R, Danesh J, Smith GD, DeMets D, Evans S, Law M, MacMahon S, Martin S, Neal B, Poulter N, Preiss D, Ridker P, Roberts I, Rodgers A, Sandercock P, Schulz K, Sever P, Simes J, Smeeth L, Wald N, Yusuf S, Peto R
doi: 10.1016/
Benefits of Statin Therapy in Patients With Acute Myocardial Infarction With Serum Low-Density Lipoprotein Cholesterol ≤ 50 mg/dl
Am J Cardiol.
Piao ZH, Jin L, Kim JH, Ahn Y, Kim YJ, Cho MC, Kim CJ, Kim HS, Liu B, Jeong MH; Other Korea Acute Myocardial Infarction Registry (KAMIR) Investigators
doi: 10.1016/j.amjcard.
COMMENTED
Type 2 Diabetes
Using Real-World Data to Predict Findings of an Ongoing Phase IV Cardiovascular Outcome Trial - Cardiovascular Safety of Linagliptin vs. Glimepiride
Diabetes Care.
Patorno E, Schneeweiss S, Gopalakrishnan C, Martin D, Franklin JM
doi: 10.2337/dc19-0069.
COMMENTED
Lipids
Baseline and on-statin treatment lipoprotein(a) levels for prediction of cardiovascular events: individual patient-data meta-analysis of statin outcome trials
Lancet.
Willeit P, Ridker PM, Nestel PJ, Simes J, Tonkin AM, Pedersen TR, Schwartz GG, Olsson AG, Colhoun HM, Kronenberg F, Drechsler C, Wanner C, Mora S, Lesogor A, Tsimikas S
doi: 10.1016/S0140-
Lipids
Patient Characteristics and Real-World Treatment Patterns Among Early Users of PCSK9 Inhibitors
Am J Cardiovasc Drugs.
Rane PB, Patel J, Harrison DJ, Shepherd J, Leith A, Bailey H, Piercy J
doi: 10.1007/s40256-017-0246-z.
Effect of Statin Treatment vs Usual Care on Primary Cardiovascular Prevention Among Older Adults: The ALLHAT-LLT Randomized Clinical Trial
JAMA Intern Med.
Han BH, Sutin D, Williamson JD, Davis BR, Piller LB, Pervin H, Pressel SL, Blaum CS; ALLHAT Collaborative Research Group
doi: 10.1001/jamainternmed.
COMMENTED
Lipids
Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials
Lancet.
Cholesterol Treatment Trialists' Collaboration
doi: org/10.1016/S0140-
COMMENTED
Diabetes - General
Statin therapy for primary prevention in the elderly and its association with new-onset diabetes, cardiovascular events and all-cause mortality
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Am J Med
Lavie G, Hoshen M, Leibowitz M, Benis A, Akriv A, Balicer R, Reges O
doi: 10.1016/j.amjmed.2020.09.058
COMMENTED
Type 2 Diabetes
Kidney outcomes associated with use of SGLT2 inhibitors in real-world clinical practice (CVD-REAL 3): a multinational observational cohort study
★ 2
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Lancet Diabetes Endocrinol.
Heerspink HJL, Karasik A, Thuresson M, Melzer-Cohen C, Chodick G, Khunti K, Wilding JPH, Garcia Rodriguez LA, Cea-Soriano L, Kohsaka S, Nicolucci A, Lucisano G, Lin FJ, Wang CY, Wittbrodt E, Fenici P, Kosiborod M
doi: 10.1016/S2213-8587(19)30384-5.